2025-12-20 - Analysis Report
Okay, here's a comprehensive analysis of BlackRock (BLK) based on the data provided.

**1) Return Comparison with S&P 500 (VOO)**

*   **Company Overview:** BlackRock Inc. is a global investment management corporation.
*   **Cumulative Return: BLK = 54.54%, VOO = 100.88%**
*   **Divergence:**  BLK is currently lagging the S&P 500's performance. The divergence of -44.1% indicates that BLK's cumulative return is significantly lower than the S&P 500's. The relative divergence of 6.7 means the current divergence sits near the bottom of the historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 48.0% | 61.2% | 20.0% | 0.1 | 79.7 |
| 2016-2018  | 7.0% | 68.1% | -8.0% | 0.1 | 61.0 |
| 2017-2019  | 18.0% | 69.4% | -5.0% | -0.4 | 78.0 |
| 2018-2020  | -2.0% | 81.8% | -25.0% | -0.3 | 112.0 |
| 2019-2021  | 67.0% | 81.8% | 20.0% | -0.2 | 142.1 |
| 2020-2022  | -2.0% | 81.8% | -1.0% | 2.2 | 109.9 |
| 2021-2023  | 6.0% | 76.8% | 4.0% | 3.0 | 126.0 |
| 2022-2024  | 24.0% | 78.6% | 3.0% | 3.1 | 159.1 |
| 2023-2025  | 20.0% | 78.6% | -45.0% | 1.3 | 164.5 |

*   **CAGR:** Fluctuates significantly year-to-year, with some periods showing strong growth and others stagnation or decline.
*   **MDD:** High Maximum Drawdown values indicate substantial risk and volatility. MDD consistently stays over 60%.
*   **Alpha:** The alpha is quite variable, with some periods showing positive alpha (outperformance compared to the market) and others showing negative alpha (underperformance). The most recent period (2023-2025) shows a significant negative alpha.
*   **Beta:**  Beta values fluctuate. High Beta values over 1.0 mean that the stock is more volatile than the market.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 1060.17
*   **Previous Close:** 1064.99
*   **Change:** -0.45
*   **5-day SMA:** 1068.092
*   **20-day SMA:** 1055.8772
*   **60-day SMA:** 1098.6028

*Analysis:* The current price is slightly below the previous close, and the 5-day SMA is above the 20-day SMA, which is a short-term bullish signal. However, both the 5-day and 20-day SMAs are below the 60-day SMA, suggesting that the stock is in a short-term uptrend but a longer-term downtrend.

**3) RSI, PPO, and Divergence Analysis**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommended)
*   **RSI:** 54.20 (Neutral – neither overbought nor oversold)
*   **PPO:** 0.2249 (Slightly above zero, indicating a minor bullish trend)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) Dividend_5.21
*   **Recent (20 days) relative divergence change:** 2.8 (+) - Short-term rise
*   **Expected Return (%):** -124.9%

*Analysis:*

*   The MRI suggests a medium investment recommendation, implying moderate risk.
*   The RSI is neutral.
*   The positive PPO suggests a slight upward momentum.
*   The negative expected return is alarming and needs to be carefully considered. This projects significant underperformance relative to the S&P 500 over a long-term investment horizon (2+ years).
*   The change in relative divergence suggests a recent upward trend, which contradicts the data from expected return.

**4) Recent News & Significant Events**

*   **IVZ vs. BLK Value Comparison:**  Indicates analysis comparing BlackRock to a competitor.
*   **BlackRock Stock Split:** Could impact share price and investor sentiment.
*   **Deutsche Bank Downgrade:** Negative analyst sentiment could pressure the stock.
*   **BlackRock/Dalio & "Trump Accounts":**  Political news may generate controversy and impact investor perception.
*   **AI & Infrastructure Fund Influence:**  Highlights BlackRock's potential activity in significant market trends.

*Analysis:* The news is mixed, with positive news (stock split, possible fund allocations to growing markets like AI) offset by negative news (downgrade, potential political controversy).

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean 1.71)
*   **Target Price (avg/high/low):** 1319.33 / 1514.00 / 1170.00

*Analysis:* Despite the recent negative news, the analyst consensus remains positive, with a "Buy" rating and a significant upside target price.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2024-08-06  | 10.07 | 4.80 B$   |
| 2024-05-07  | 10.58 | 4.73 B$   |
| 2023-11-06  | 10.75 | 4.52 B$   |
| 2023-08-04  | 9.13  | 4.46 B$   |
| 2024-08-06  | 9.13  | 4.46 B$   |

*Analysis:* EPS and revenue show general upward trend over the past year, although there is some volatility.

**6) Financial Information**

Revenue and Profitability:

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $6.51B    | 45.94%        |
| 2025-06-30   | $5.42B    | 47.87%        |
| 2025-03-31   | $5.28B    | 47.88%        |
| 2024-12-31   | $5.68B    | 49.25%        |
| 2024-09-30   | $5.20B    | 51.13%        |

Capital and Profitability:

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-09-30   | $55.52B   | 2.38%     |
| 2025-06-30   | $49.14B   | 3.24%     |
| 2025-03-31   | $48.04B   | 3.14%     |
| 2024-12-31   | $47.49B   | 3.52%     |
| 2024-09-30   | $41.18B   | 3.96%     |

*Analysis:*

*   **Revenue:** Shows increasing trend from 2024-09-30 to 2025-09-30.
*   **Profit Margin:** Profit margin declined, suggesting a possible increase in costs.
*   **Equity:** Equity increased, demonstrating growth.
*   **ROE:** ROE has declined, indicating lower profitability per dollar of equity.

**7) Comprehensive Analysis**

BlackRock (BLK) presents a mixed picture. While it has seen revenue growth and analysts remain optimistic, it has significantly underperformed the S&P 500 recently. The declining profit margins, ROE, and very negative "Expected Return" are concerning and outweigh the positive trend indicated by the revenue and equity data. The high MDD indicates that the stock is high risk/high reward. The MRI, PPO, RSI, and price action indicators suggest moderate, short-term investment potential.

**Recommendation:**

Based on this analysis, a cautious approach is warranted. The significant underperformance relative to the S&P 500, the negative "Expected Return", high MDD, and mixed news environment raise red flags. While analysts remain optimistic, these factors should be carefully considered.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.